Episodic Use of Pre-Exposure Prophylaxis Among Young Cisgender Women in Siaya County, Kenya.

Autor: Corneli A; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA., Perry B; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA., Ngoje DO; Impact Research and Development Organization, Kisumu, Kenya., Molokwu N; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA., Strack R; Department of Public Health Education, School of Health and Human Sciences, University of North Carolina Greensboro, Greensboro, North Carolina, USA., Agot K; Impact Research and Development Organization, Kisumu, Kenya.
Jazyk: angličtina
Zdroj: AIDS patient care and STDs [AIDS Patient Care STDS] 2022 Oct; Vol. 36 (10), pp. 379-388.
DOI: 10.1089/apc.2022.0076
Abstrakt: The concept "seasons of risk" promotes use of pre-exposure prophylaxis (PrEP) only during periods of HIV risk. PrEP guidelines are aligned on daily use in women having vaginal sex during a risk period, and daily use for 28 days after the last potential exposure is recommended. However, when starting a "season of risk," guidelines vary on "time to protection," and unknowns remain in pharmacological research on PrEP protection in this population. During our iterative research on PrEP persistence using photovoice and in-depth interviews, we identified an ineffective pattern of PrEP use based on current guidelines-that is, routine, episodic use-among young cisgender women (YCW) in Siaya County, Kenya. Through same-group ( n  = 33 participants) and mixed-group ( n  = 31 participants) photovoice activities with YCW taking PrEP and female peers, participants explained that YCW associate their HIV risk with the sexual behaviors of their male partners who frequently travel from home. PrEP is considered unnecessary when partners are away because of no perceived risk. YCW re-start PrEP on or around the day of their partners' return because of heightened risk perceptions. Among the YCW interviewed ( n  = 18), nearly all of their partners traveled for about 1 week to 1 month at a time; about one-third of these women reported stopping PrEP during their partners' absence and re-starting it soon before or immediately upon their partners' arrival home. Additional research is critically needed to better inform PrEP guidelines and the decisions adolescent girls and young women make on how to use PrEP based on their risk context. In the interim, counseling on current dosing guidance when stopping and re-starting PrEP within a "season of risk" is needed.
Databáze: MEDLINE